• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

提高澳大利亚患盆腔浆液性癌高危女性降低风险的输卵管卵巢切除术的质量。

Improved quality of risk-reducing salpingo-oophorectomy in Australasian women at high risk of pelvic serous cancer.

作者信息

Lee Y C, Bressel M, Grant P, Russell P, Smith C, Picken S, Camm S, Kiely B E, Milne R L, McLachlan S A, Hickey M, Friedlander M L, Hopper J L, Phillips K A

机构信息

Division of Cancer Medicine, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.

Centre of Biostatistics and Clinical Trials (BaCT) Peter MacCallum Cancer Centre, East Melbourne, VIC, Australia.

出版信息

Fam Cancer. 2017 Oct;16(4):461-469. doi: 10.1007/s10689-017-9977-x.

DOI:10.1007/s10689-017-9977-x
PMID:28285341
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5603648/
Abstract

OBJECTIVES

The quality of risk-reducing salpingo-oophorectomy (RRSO) performed in Australasian women was previously reported to be suboptimal. Here we describe the quality of RRSO performed since 2008 in women enrolled in the same cohort and determine whether it has improved.

DESIGN

Prospective cohort study of women at high risk of pelvic serous cancer (PSC) in kConFab. Eligible women had RRSO between 2008 and 2014 and their RRSO surgical and pathology reports were reviewed. "Adequate" surgery and pathology were defined as complete removal and paraffin embedding of all ovarian and extra-uterine fallopian tube tissue, respectively. Associations between clinical factors and "adequate" pathology were assessed using logistic regression. Data were compared with published cohort data on RRSO performed prior to 2008 using Chi square test.

RESULTS

Of 164 contemporary RRSOs performed in 78 centres, 158/159 (99%) had "adequate" surgery and 108/164 (66%) had "adequate" pathology. Surgery performed by a gynaecologic oncologist rather than a general gynaecologist [OR 8.2, 95%CI (3.6-20.4), p < 0.001], surgery without concurrent hysterectomy [OR 2.5, 95%CI (1.1-6.0), p = 0.03], more recent year of surgery [OR 1.4, 95%CI (1.1-1.8), p = 0.02], and clinical notation that indicated high risk [OR 19.4, 95%CI (3.1-385), p = 0.008] were independently associated with "adequate" pathology. Both surgery and pathology were significantly more likely to be "adequate" (p < 0.001) in this contemporary sample.

CONCLUSION

The quality of RRSOs has significantly improved since our last report. Surgery by a gynaecologic oncologist who informs the pathologist that the woman is at high risk for PSC is associated with optimal RRSO pathology.

摘要

目的

此前有报道称,在澳大拉西亚女性中进行的降低风险的输卵管卵巢切除术(RRSO)质量欠佳。在此,我们描述了自2008年以来在同一队列中登记的女性所接受的RRSO的质量,并确定其质量是否有所改善。

设计

对kConFab中盆腔浆液性癌(PSC)高危女性进行的前瞻性队列研究。符合条件的女性在2008年至2014年间接受了RRSO,并对她们的RRSO手术和病理报告进行了审查。“充分的”手术和病理分别定义为所有卵巢和子宫外输卵管组织的完整切除和石蜡包埋。使用逻辑回归评估临床因素与“充分的”病理之间的关联。使用卡方检验将数据与2008年之前发表的关于RRSO的队列数据进行比较。

结果

在78个中心进行的164例当代RRSO中,158/159例(99%)进行了“充分的”手术,108/164例(66%)有“充分的”病理。由妇科肿瘤学家而非普通妇科医生进行的手术[比值比(OR)8.2,95%置信区间(CI)(3.6 - 20.4),p < 0.001]、未同时进行子宫切除术的手术[OR 2.5,95%CI(1.1 - 6.0),p = 0.03]、更近年份的手术[OR 1.4,95%CI(1.1 - 1.8),p = 0.02]以及表明高危的临床记录[OR 19.4,95%CI(3.1 - 385),p = 0.008]与“充分的”病理独立相关。在这个当代样本中,手术和病理更有可能是“充分的”(p < 0.001)。

结论

自我们上次报告以来,RRSO的质量有了显著提高。由告知病理学家该女性患PSC高危的妇科肿瘤学家进行的手术与最佳RRSO病理相关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b2f6/5603648/2a720c2cc93b/10689_2017_9977_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b2f6/5603648/2a720c2cc93b/10689_2017_9977_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b2f6/5603648/2a720c2cc93b/10689_2017_9977_Fig1_HTML.jpg

相似文献

1
Improved quality of risk-reducing salpingo-oophorectomy in Australasian women at high risk of pelvic serous cancer.提高澳大利亚患盆腔浆液性癌高危女性降低风险的输卵管卵巢切除术的质量。
Fam Cancer. 2017 Oct;16(4):461-469. doi: 10.1007/s10689-017-9977-x.
2
The Role of Routine Peritoneal and Omental Biopsies at Risk-Reducing Salpingo-Oophorectomy.常规腹膜和网膜活检在降低风险的输卵管卵巢切除术中的作用
J Minim Invasive Gynecol. 2017 Jul-Aug;24(5):772-776. doi: 10.1016/j.jmig.2017.03.001. Epub 2017 Mar 8.
3
Adequacy of risk-reducing gynaecologic surgery in BRCA1 or BRCA2 mutation carriers and other women at high risk of pelvic serous cancer.BRCA1 或 BRCA2 基因突变携带者和其他盆腹腔浆液性癌高危女性的降低风险妇科手术的充分性。
Fam Cancer. 2011 Sep;10(3):505-14. doi: 10.1007/s10689-011-9435-0.
4
The prevalence of occult ovarian cancer in the series of 155 consequently operated high risk asymptomatic patients - Slovenian population based study.155 例连续手术的高危无症状患者中隐匿性卵巢癌的发生率 - 基于斯洛文尼亚人群的研究。
Radiol Oncol. 2020 May 28;54(2):180-186. doi: 10.2478/raon-2020-0020.
5
Quantitative analysis of γ-H2AX and p53 nuclear expression levels in ovarian and fallopian tube epithelium from risk-reducing salpingo-oophorectomies in BRCA1 and BRCA2 mutation carriers.对BRCA1和BRCA2突变携带者进行降低风险的输卵管卵巢切除术所获得的卵巢和输卵管上皮中γ-H2AX和p53核表达水平的定量分析。
Int J Gynecol Pathol. 2014 May;33(3):309-16. doi: 10.1097/PGP.0b013e31829c673b.
6
Pathological findings following risk-reducing salpingo-oophorectomy in BRCA mutation carriers: A systematic review and meta-analysis.BRCA 基因突变携带者预防性输卵管卵巢切除术的病理结果:系统评价和荟萃分析。
Eur J Surg Oncol. 2020 Jan;46(1):139-147. doi: 10.1016/j.ejso.2019.09.002. Epub 2019 Sep 5.
7
Retrospective study of a 16 year cohort of BRCA1 and BRCA2 carriers presenting for RRSO: Prevalence of invasive and in-situ carcinoma, with follow-up.回顾性研究 16 年 BRCA1 和 BRCA2 携带者接受 RRSO 的队列:浸润性和原位癌的患病率,并进行随访。
Gynecol Oncol. 2019 May;153(2):326-334. doi: 10.1016/j.ygyno.2019.03.003. Epub 2019 Mar 18.
8
Clinical significance of risk-reducing salpingo-oophorectomy in patients with BRCA1/2 mutation.BRCA1/2 基因突变患者行预防性输卵管卵巢切除术的临床意义。
J Gynecol Obstet Hum Reprod. 2023 Oct;52(8):102642. doi: 10.1016/j.jogoh.2023.102642. Epub 2023 Aug 11.
9
Primary fallopian tube carcinoma (PFTC) in a BRIP-1 mutation carrier: the first case report.BRIP1 突变携带者中的原发性输卵管癌:首例病例报告。
Fam Cancer. 2020 Oct;19(4):291-295. doi: 10.1007/s10689-020-00179-0. Epub 2020 Apr 24.
10
Support of the 'fallopian tube hypothesis' in a prospective series of risk-reducing salpingo-oophorectomy specimens.前瞻性系列降低风险的输卵管卵巢切除术标本中对“输卵管假说”的支持。
Eur J Cancer. 2013 Jan;49(1):132-41. doi: 10.1016/j.ejca.2012.07.021. Epub 2012 Aug 21.

引用本文的文献

1
Recommendations for diagnosing STIC: a systematic review and meta-analysis.诊断 STIC 的建议:系统评价和荟萃分析。
Virchows Arch. 2022 Apr;480(4):725-737. doi: 10.1007/s00428-021-03244-w. Epub 2021 Dec 1.
2
The Effect of Prophylactic Adnexectomy on the Quality of Life and Psychosocial Functioning of Women with the Mutations.预防性附件切除术对携带突变的女性生活质量和社会心理功能的影响。
Int J Environ Res Public Health. 2019 Dec 9;16(24):4995. doi: 10.3390/ijerph16244995.

本文引用的文献

1
Uterine Cancer After Risk-Reducing Salpingo-oophorectomy Without Hysterectomy in Women With BRCA Mutations.携带BRCA突变的女性在未行子宫切除的降低风险输卵管卵巢切除术后发生子宫癌
JAMA Oncol. 2016 Nov 1;2(11):1434-1440. doi: 10.1001/jamaoncol.2016.1820.
2
Genetic/Familial High-Risk Assessment: Breast and Ovarian, Version 2.2015.遗传/家族性高风险评估:乳腺和卵巢,第 2.2015 版。
J Natl Compr Canc Netw. 2016 Feb;14(2):153-62. doi: 10.6004/jnccn.2016.0018.
3
Ovarian cancer screening and mortality in the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS): a randomised controlled trial.
英国卵巢癌筛查协作试验(UKCTOCS)中的卵巢癌筛查与死亡率:一项随机对照试验
Lancet. 2016 Mar 5;387(10022):945-956. doi: 10.1016/S0140-6736(15)01224-6. Epub 2015 Dec 17.
4
A risk prediction algorithm for ovarian cancer incorporating BRCA1, BRCA2, common alleles and other familial effects.一种纳入BRCA1、BRCA2、常见等位基因及其他家族性因素的卵巢癌风险预测算法。
J Med Genet. 2015 Jul;52(7):465-75. doi: 10.1136/jmedgenet-2015-103077. Epub 2015 May 29.
5
Pathologic findings at risk-reducing salpingo-oophorectomy: primary results from Gynecologic Oncology Group Trial GOG-0199.降低风险的输卵管卵巢切除术的病理结果:妇科肿瘤学组试验GOG-0199的初步结果
J Clin Oncol. 2014 Oct 10;32(29):3275-83. doi: 10.1200/JCO.2013.54.1987. Epub 2014 Sep 8.
6
A major step forward for BRCA1/2-related cancer risk management.BRCA1/2相关癌症风险管理向前迈出的重要一步。
J Clin Oncol. 2014 May 20;32(15):1531-3. doi: 10.1200/JCO.2013.54.8925. Epub 2014 Mar 31.
7
Impact of oophorectomy on cancer incidence and mortality in women with a BRCA1 or BRCA2 mutation.BRCA1 或 BRCA2 基因突变女性行卵巢切除术对癌症发病率和死亡率的影响。
J Clin Oncol. 2014 May 20;32(15):1547-53. doi: 10.1200/JCO.2013.53.2820. Epub 2014 Feb 24.
8
Breast and ovarian cancer risks in a large series of clinically ascertained families with a high proportion of BRCA1 and BRCA2 Dutch founder mutations.在一系列临床确诊的家庭中,BRCA1和BRCA2荷兰始祖突变比例较高时的乳腺癌和卵巢癌风险。
J Med Genet. 2014 Feb;51(2):98-107. doi: 10.1136/jmedgenet-2013-101974. Epub 2013 Nov 27.
9
Clinical outcome of isolated serous tubal intraepithelial carcinomas (STIC).孤立性输卵管上皮内浆液性癌(STIC)的临床转归。
Int J Gynecol Cancer. 2013 Nov;23(9):1603-11. doi: 10.1097/IGC.0b013e3182a80ac8.
10
New views on the pathogenesis of high-grade pelvic serous carcinoma with suggestions for advancing future research.高级别盆腔浆液性癌发病机制的新观点及对推进未来研究的建议。
Gynecol Oncol. 2012 Dec;127(3):645-50. doi: 10.1016/j.ygyno.2012.08.023. Epub 2012 Aug 29.